scPharmaceuticals Inc (SCPH)


Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading scPharmaceuticals Inc chart...

About the Company

scpharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (iv) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.

$119M

Total Revenue

88

Employees

$210M

Market Capitalization

-4.01

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SCPH News

scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript

2d ago, source: InvestingChannel on MSN

Q4 2023 Earnings Call March 13, 2024 scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations ...

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

5d ago, source:

Generated 4Q 2023 net FUROSCIX® revenue of $6.1 million, at the upper end of the range provided in January and representing ...

Buy Rating Affirmed for scPharmaceuticals Amidst Revenue Surge and Solid Financial Footing

3d ago, source: Business Insider

Begin your TipRanks Premium journey today. scPharmaceuticals (SCPH) Company Description: scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous ...

scPharmaceuticals Inc Registered Shs hosts conference call for investors

9d ago, source:

The company, scPharmaceuticals Inc Registered Shs, is set to host investors and clients on a conference call on 3/13/2024 1:49:25 PM. The call ...

scPharmaceuticals Q4 2023 Earnings Preview

on MSN ago, source:

Pharmaceuticals (NASDAQ:SCPH) is scheduled to announce Q4 earnings results on Wednesday, March 13th, after market close. The consensus EPS Estimate is -$0.41 (-51.9% Y/Y) and the consensus Revenue ...

scPharmaceuticals Inc.

19d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

5d ago, source: Morningstar

March 13, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the ...

scPharmaceuticals Inc (SCPH) Q4 2023 Earnings Call Transcript

5d ago, source: Seeking Alpha

Greetings, and welcome to scPharmaceuticals Fourth Quarter and Full year 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. [Operator Instructions] As a ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...